Ultralife Corporation
Ultralife Corporation Q3 FY2025 earnings call
November 18, 2025 · fiscal period ended 2025-09
EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2025-11-18
Management highlights
- Q3 sales were $43.4 million with an operating loss of $1 million, including a one-time adjustment of $1.1 million. Revenue grew year-over-year but faced gross margin challenges due to supply chain quality issues in Battery & Energy. Communications business weighed on earnings. - Decided to close Calgary location, with production relocated to Houston, anticipating annual savings of ~$0.8 million in 2026. - Progressing with company-wide rebranding initiative, first phase targeted for Q4 completion. - In Battery & Energy: Received BA-53 battery award, conformal wearable battery shipping production quantities, 123A follow-on PEO, thin cell technology for medical wearable sector, expanded X5 medical car products. - In Communications: Expanding ruggedized server case portfolio, completed initial design for communication and control solution, showcased new amplifier and Crescent server at defense show, working on next high-performance amplifier, received PO for prototype electronic warfare amplifiers.
Segment performance
Consolidated revenues totaled $43.4 million. The Battery & Energy Products segment had revenues of $39.9 million, accounting for 91.9% of total revenues. The Communications Systems segment had revenues of $3.4 million, making up 7.8% of total revenues. In Q3, the Battery & Energy Products business had gross profit of $8.8 million, with a gross margin of 22.1% compared to 24.7% last year. The Communications Systems segment had gross profit of $0.8 million, with a gross margin of 23.3% compared to 20% last year. Consolidated gross profit was $9.6 million, an increase of 10.8% over the prior year, but consolidated gross margin was 22.2%, a 210 basis point decline from the prior year's 24.3%.
Guidance
- Anticipate annual savings of approximately $0.8 million throughout 2026 from closing Calgary location. - New products in development across both businesses, with expected production and orders in 2026 for various items like amplifiers, Crescent server, conformal wearable battery, etc.
Risks
- Uncertain global economic conditions. - Reductions in revenue from key customers. - Delays or reductions in U.S. and foreign military spending. - Acceptance of new products on a global basis. - Disruptions or delays in supply of raw materials and components due to business conditions, global conflicts, weather, etc.
Q&A highlights
Q: None A: None
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | $-0.07 | $0.21 | -133.3% | $0.01 |
| Revenue | $43.4M | $52.2M | -17.0% | $35.7M |
Transcript
November 18, 2025Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.